Aesthetics Biomedical Inc.

Aesthetics Biomedical Inc. is a privately-owned US medical device manufacturer headquartered in Phoenix, Arizona, specializing in aesthetic and dermatological treatment systems. Founded in 2016, the company develops and manufactures novel aesthetic devices and combination therapies for the global market. Their primary product is UltraVision™, an industry-first ultrasound-assisted radiofrequency (RF) microneedling system that combines ultrasound imaging and mapping with uniform RF microneedling delivery for personalized skin treatments. The device offers ultrasound skin depth precision, colorblind versatility, minimal downtime, and uniform energy delivery. UltraVision™ is backed by peer-reviewed clinical research published in the Journal of Cosmetic Dermatology. The company also manufactures SoME® Skincare, the first autologous topical skincare product designed to complement and extend treatment results, featuring a proprietary blend of personalized ingredients for custom at-home cosmetic applications. Both products are US-made and marketed to aesthetic practitioners, dermatologists, and medical spas. The company positions itself as a leader in breakthrough technologies and combination therapies, emphasizing precision, personalization, and safety in aesthetic treatment delivery.